Colgate-Palmolive's stock has risen nearly 22% this year, but the company struggles with declining sales in North America and margin pressures from rising oil costs. The upcoming Q3 earnings report will be closely watched for signs of U.S. market recovery and margin stability. While the company has a strong dividend history and global market share, its current high valuation depends on improved performance in the U.S. and cost management. Analysts have recently lowered earnings estimates, highlighting risks to the stock's premium price.
Colgate-Palmolive trades at USD 93.72 on Pluang as of Oct 26, 2026 20:51 WIB, down 0.35% for the day. The stock holds a dividend yield of 2.25% and a market cap of $74.97 billion, reflecting its status as a major consumer staples company. This context highlights the significance of the upcoming Q3 earnings report mentioned in the news, which investors will watch for signs of recovery and margin stability in the U.S. market.
Procter & Gamble (P&G) and Colgate-Palmolive both raised dividends and beat earnings estimates, but P&G offers a higher dividend yield (2.61% vs. 2.15%) and a stronger long-term dividend growth record. P&G covers its dividends well with free cash flo...
Colgate-Palmolive Company continues to be a reliable long-term investment due to its return to volume growth, record-high gross margins of 61.5%, and benefits from emerging markets. The stock acts as a volatility hedge during market turbulence, outpe...
